Literature DB >> 7545339

Prevalence of antibodies to hepatitis C virus and other markers in Jamaica.

S D King1, R Y Dodd, G Haynes, H H Wynter, M T Sullivan, G R Serjeant, E Choo-Kang, E Michael.   

Abstract

Three population groups, 1500 blood donors, 513 antenatal women representing a normal population group and 250 sicklers representing a multiply transfused group were studied to determine the prevalence of hepatitis C viral (HCV) infection in Jamaica. The relationship to liver enzyme levels, hepatitis B infection, syphilis and HIV infection was also investigated. Sera were screened by enzyme-linked immunoassay (EIA) for anti-HCV C100-3 and subsequently tested by a supplementary second generation recombinant immunoblot assay (RIBA). In the blood donors, the prevalence of anti-HCV was low, 0.3%-0.4%, the same level as that reported by several European countries. In the multiply transfused sicklers, the prevalence was more than seven times higher. No HCV infection was detected in the antenatal group. There was little correlation between HCV infection and surrogate markers alanine aminotransferase (ALT) and antibody to hepatitis B core antigen (anti-HBc) and no correlation with sexually transmitted diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545339

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  4 in total

1.  Hepatitis B and C viruses and sexually transmitted disease patients in Jamaica.

Authors:  M Smikle; G Dowe; T Hylton-Kong; E Williams
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  Hepatitis C and blood transfusion among children attending the Sickle Cell Clinic at Mulago Hospital, Uganda.

Authors:  S O M Namasopo; C Ndugwa; J K Tumwine
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

3.  Hepatitis C virus (HCV) genotypes in the Caribbean island of Martinique: evidence for a large radiation of HCV-2 and for a recent introduction from Europe of HCV-4.

Authors:  Jenny Martial; Yoann Morice; Sylvie Abel; André Cabié; Christelle Rat; Frédéric Lombard; André Edouard; Serge Pierre-Louis; Philippe Garsaud; Odile Béra; Roger Chout; Emmanuel Gordien; Paul Deny; Raymond Césaire
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 4.  HCV in sickle cell disease.

Authors:  Mohamed Hassan; Syed Hasan; Oswaldo Castro; Samuel Giday; Alpha Banks; Duane Smoot
Journal:  J Natl Med Assoc       Date:  2003-09       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.